Stereotactic body radiotherapy (SBRT) for patients with metastatic cancer, especially when
characterised by a low tumour burden (ie, oligometastatic disease), receiving targeted …

Radiation therapy (RT) plays a key role in curative-intent treatments for head and neck
cancers. Its use is indicated as a sole therapy in early stage tumors or in combination with …

Background and purpose Both stereotactic radiotherapy (SRT) and immune-or targeted
therapy play an increasingly important role in personalized treatment of metastatic disease …

Purpose Recurrent head and neck cancer is associated to a poor survival prognosis. A high
toxicity rate is demonstrated when surgery and/or radiotherapy and/or chemotherapy are …

Purpose Salvage options for unresectable locally recurrent, previously irradiated squamous
cell carcinoma of the head and neck (rSCCHN) are limited. Although the addition of …

Background Local and/or regional recurrence and metachronous primary tumor arising in a
previously irradiated area are rather frequent events in patients with head and neck …

Purpose To review our 15-year institutional experience using intensity modulated radiation
therapy (IMRT) to reirradiate patients with head and neck squamous cell carcinomas …

Background In the management of head and neck cancer (HNC) patients, local recurrence
is a common cause of treatment failure. Only a few patients with recurrent HNC (rHNC) are …

The International Commission on Radiation Units and Measurements - Hans-Georg Menzel,
2012 Skip to main content Scheduled maintenance on Monday, November 20th, with …

Retreatment of recurrent or second primary head and neck cancers occurring in a previously
irradiated field is complex. Few guidelines exist to support practice. We performed an …